Damien Tampling - Xero Chief Officer
| XRO Stock | 171.00 2.38 1.41% |
Executive
Damien Tampling is Chief Officer of Xero
| Address | Xero One, Wellington, New Zealand, 6011 |
| Phone | 64 4 819 4800 |
| Web | https://www.xero.com |
Xero Management Efficiency
The company has return on total asset (ROA) of 0.0697 % which means that it generated a profit of $0.0697 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1405 %, meaning that it generated $0.1405 on every $100 dollars invested by stockholders. Xero's management efficiency ratios could be used to measure how well Xero manages its routine affairs as well as how well it operates its assets and liabilities. Total Current Liabilities is likely to gain to about 277.1 M in 2024. Liabilities And Stockholders Equity is likely to gain to about 3.1 B in 2024Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Damian Arena | Iodm | N/A | |
| Chris Ward | Iodm | N/A | |
| Thomas Jarrett | Recce | N/A | |
| Yuval Cohen | Audio Pixels Holdings | N/A | |
| Carolyn Noumertzis | Regis Healthcare | N/A | |
| AGIA BBus | Regis Healthcare | N/A | |
| Jodie Haydon | Regis Healthcare | N/A | |
| Justin Reynolds | Recce | N/A | |
| BA BCom | Recce | N/A | |
| James Burke | Iodm | N/A | |
| Maggie Niewidok | Recce | N/A | |
| Michelle Baker | Regis Healthcare | N/A | |
| Arthur Kollaras | Recce | N/A | |
| Imtiaz Bhayat | Regis Healthcare | N/A | |
| John Prendergast | Recce | 70 | |
| Alex Wilkinson | Iodm | N/A | |
| Rick FCA | Regis Healthcare | N/A | |
| Graham Smith | Iodm | N/A | |
| Michael Horwood | Regis Healthcare | N/A | |
| BBus ACA | Iodm | 54 | |
Management Performance
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0697 |
Xero Leadership Team
Elected by the shareholders, the Xero's board of directors comprises two types of representatives: Xero inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xero. The board's role is to monitor Xero's management team and ensure that shareholders' interests are well served. Xero's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xero's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Diya Jolly, Chief Officer | ||
| Steven BE, Chief Officer | ||
| Rachael Powell, Chief Officer | ||
| Ashley Grech, Chief Officer | ||
| Nicole Reid, Chief Officer | ||
| Anna Curzon, Chief Officer | ||
| Alexander Schirmeister, Managing Markets | ||
| BEc FCIS, Company Officer | ||
| Kirsty GodfreyBilly, Chief Officer | ||
| Nicole Mehalski, Head Relations | ||
| Damien Tampling, Chief Officer | ||
| Sukhinder Cassidy, Chief Officer | ||
| Michael Strickman, Chief Officer | ||
| Angad Soin, Chief Officer | ||
| Rod Drury, Founder Director | ||
| Joseph Lyons, Managing APAC | ||
| Mark Rees, Chief Officer | ||
| Toby CFA, Head Relations | ||
| Kate McLaughlin, General Communications |
Xero Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xero a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.14 | ||||
| Return On Asset | 0.0697 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 25.43 B | ||||
| Shares Outstanding | 152.81 M | ||||
| Shares Owned By Insiders | 6.19 % | ||||
| Shares Owned By Institutions | 27.19 % | ||||
| Price To Book | 15.09 X | ||||
| Price To Sales | 13.52 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xero Stock Analysis
When running Xero's price analysis, check to measure Xero's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xero is operating at the current time. Most of Xero's value examination focuses on studying past and present price action to predict the probability of Xero's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xero's price. Additionally, you may evaluate how the addition of Xero to your portfolios can decrease your overall portfolio volatility.